Drug LitigationDo You Know about the FDA’s Paxil Warning?

March 10, 2012

GlaxoSmithKlein, the manufacturer of the popular – and dangerous – antidepressant Paxil (paroxetine), is responsible for warning consumers about the risks of its products. Tragically, thousands of women never receive the message which the FDA requires GSK to communicate: Paxil is categorized as a type D drug, a strong indication of the FDA’s concern that Paxil may cause birth defects in the children of pregnant patients.

 

More than 1,000 lawsuits have been filed against GSK for the harmful effects of this dangerous prescription selective serotonin reuptake inhibitor (SSRI). It’s little wonder why these litigants have filed claims against the pharmaceudical giant: Paxil and other SSRIs are suspected of significantly increasing the risk that developing children are born with clubbed foot, cleft lip, brain deformities, and other painful side effects.

 

Nachawati Law Group defends patients and victims like you. If your child has been injured as a result of your Paxil or other SSRI prescription, you should contact our professionals and dangerous drug experts immediately. We know how to fight for you!  

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.

https://ntrial.com/ntrial/wp-content/uploads/Nachawati-Law-logo-White-2-160x25.png

©2025 Nachawati Law Group           Terms and Conditions | Privacy Policy